Tuesday, July 14, 2026
Health

Phenylephrine vs Noradrenaline: New Review Guides Caesarean Section Blood Pressure Management

133 people reading this right now
Phenylephrine vs Noradrenaline: New Review Guides Caesarean Section Blood Pressure Management

A recent literature review in Cureus compares phenylephrine and noradrenaline for preventing and treating spinal‑induced hypotension during caesarean sections, offering clinicians clearer guidance on vasopressor choice.

A new literature review published in Cureus evaluates the use of phenylephrine and noradrenaline to prevent and treat spinal‑induced hypotension in women undergoing caesarean sections. The authors analysed data from several randomized trials to determine which drug offers better haemodynamic stability and fewer adverse effects.

Details

  • Phenylephrine is a selective α‑1 adrenergic agonist that raises systemic vascular resistance.
  • Noradrenaline combines α and β adrenergic activity, potentially preserving heart rate while increasing blood pressure.
  • The review compares onset time, duration of effect, and incidence of tachycardia or reflex bradycardia.
  • Both agents were found effective, but noradrenaline showed a lower tendency to cause reflex bradycardia.
  • Authors recommend dose‑titration protocols tailored to individual patient haemodynamics.

Quotes

No direct quotations were provided in the source material.

Background

Spinal anaesthesia for caesarean delivery frequently leads to sudden drops in blood pressure, increasing the risk of maternal and fetal complications. Phenylephrine has long been the standard vasopressor, but recent evidence suggests that noradrenaline may offer advantages in maintaining heart rate and reducing side effects. This review synthesises the current evidence to aid anaesthesiologists in selecting the most appropriate agent.

Conclusion

The comparative analysis highlights that both phenylephrine and noradrenaline are viable options, with noradrenaline potentially providing a more balanced haemodynamic profile. Adoption of the review’s dosing recommendations could improve maternal safety during caesarean sections, though further large‑scale studies are needed to confirm optimal protocols.

About the author

bossprp

Share this story: WhatsAppTelegramXFacebook

Oh hi there 👋
It’s nice to meet you.

Sign up to receive awesome content in your inbox, every month.

We don’t spam! Read our privacy policy for more info.


Discover more from NewzQuest

Subscribe to get the latest posts sent to your email.

Was this helpful?
Advertisement
728×90

AI Sentiment Analysis

😊 Positive: 80%😐 Neutral: 15%😠 Negative: 5%

Leave a Reply

Discover more from NewzQuest

Subscribe now to keep reading and get access to the full archive.

Continue reading